COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: The drug (including tea, honey and royal jelly for 5 days) is delivered to the hospital along with the list of codes of patients in the intervention group (to be pr
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosis of COVID-19 Age 18-65 Having informed and written consent to participate in the study
Exclusion criteria
Exclusion criteria: Disagreement of the physician directly responsible for the patient Pregnancy and breastfeeding Allergies to the drug elements Symptoms of gastrointestinal, liver or kidney disease Incidence of drug interactions Patient dissatisfaction to continue the project for any reason Inability of the patient to receive oral medication Hypertension Having heart failure Do not take anticoagulants (aspirin, Plavix, warfarin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospitalization time. Timepoint: Before starting the study and after 5 days of using herbal supplements. Method of measurement: A researcher-made questionnaire whose validity and reliability have been assessed. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad-Reza Sharifi Alvan Abadi
Bagheiat-allah University of Medical Sciences
Outcome results
None listed